Table 1.
Clinicopathological characteristics and associations of chromosome 8q gain.
| Variable | Total | No gain | Gain | p-value |
|---|---|---|---|---|
| n = 297 | n = 276 | n = 18 | ||
| Age, median (IQR) | 62 (16) | 62 (16) | 63 (11) | 0.234 |
| Sex (%) | ||||
| Male | 216 (73) | 202 (73) | 14 (78) | 0.456 |
| Female | 81 (27) | 77 (27) | 4 (22) | |
| pT stage (%) | ||||
| 1,2 | 231 (78) | 225 (82) | 6 (33) | <0.001 |
| 3,4 | 65 (22) | 53 (18) | 12 (67) | |
| pN stage (%) | ||||
| 0 | 286 (96) | 272 (99) | 14 (78) | 0.005 |
| 1 | 11 (4) | 7 (1) | 4 (22) | |
| M stage (%) | ||||
| 0 | 259 (87) | 249 (89) | 10 (56) | <0.001 |
| 1 | 38 (13) | 30 (11) | 8 (44) | |
| Nuclear grade (%) | ||||
| ⩽2 | 152 (51) | 149 (54) | 3 (17) | <0.001 |
| >2 | 142 (49) | 127 (46) | 15 (83) | |
| CCI, median (IQR) | 1 (2) | 1 (2) | 1 (2) | 0.593 |
| Standard division | 1.69 | 1.71 | 1.47 |
CCI, Charlson comorbidity index; IQR, interquartile range.